Schizophrenia Therapeutics 2026: Improving Long-Term Patient Outcomes through Long-Acting Injectables (LAIs) and Targeted Muscarinic Agonists
Schizophrenia Treatment Advancements 2024 New Medications and Therapeutic Breakthroughs Challenges in Current Treatment Regimens Schizophrenia, affecting approximately 1% of the global population, impacts millions with symptoms ranging from hallucinations to cognitive impairments. Traditional antipsychotic medications, while effective for many, often come with side effects like weight gain,...
0 Kommentare 0 Geteilt 102 Ansichten 0 Bewertungen